US House appropriators want to extend the Food and Drug Administration’s authority to order product recalls to include all OTC ad Rx drugs, although the industry isn’t convinced the agency needs the option.
The Appropriations Committee on 9 July passed its fiscal year 2021 appropriation bill that includes the FDA’s budget with
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?